(Q33777699)

29 July 2017

1 reference

title

Cholesterol lowering and endothelial function (English)

1 reference

29 July 2017

0 references

Vogel RA

1

1 reference

PubMed ID

10569303

29 July 2017

language of work or name

English

0 references

publication date

1 November 1999

1 reference

American Journal of Medicine

29 July 2017

1 reference

29 July 2017

107

1 reference

29 July 2017

479-487

1 reference

29 July 2017

5

1 reference

Persantine and aspirin in coronary heart disease. The Persantine-Aspirin Reinfarction Study Research Group

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Cholesterol and mortality. 30 years of follow-up from the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

The pathogenesis of atherosclerosis--an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Cell proliferation in human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Are we mortgaging the medical profession?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Influence of hemodynamic forces on vascular endothelial function. In vitro studies of shear stress and pinocytosis in bovine aortic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Flow effects on prostacyclin production by cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Adhesion receptors of the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Cholesterol, cholesterol lowering, and endothelial function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

The emerging concept of vascular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Coronary risk factors, endothelial function, and atherosclerosis: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Endothelial dysfunction: does it matter? Is it reversible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the seven countries study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Molecular bases of the acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Coronary plaque disruption.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Endothelial-Dependent Mechanisms of Leukocyte Adhesion in Inflammation and Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Endothelin: a new cardiovascular regulatory peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

The L-arginine-nitric oxide pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Cellular and molecular mechanisms of endothelial cell dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Inactivation of endothelial derived relaxing factor by oxidized lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: relevance of the effect of oxidized LDL on platelet function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Beyond LDL cholesterol reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Lipoprotein(a) and Atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Effect of a single high-fat meal on endothelial function in healthy subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Endothelial dysfunction in the early stage of atherosclerosis precedes appearance of intimal lesions assessable with intravascular ultrasound

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Atherosclerosis: risk factors and the vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Hypercholesterolemia causes generalized impairment of endothelium-dependent relaxation to aggregating platelets in porcine arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

High density lipoprotein reverses inhibitory effect of oxidized low density lipoprotein on endothelium-dependent arterial relaxation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

The role of nitric oxide in endothelium-dependent vasodilation of hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Role of oxygen-derived radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

In Vivo Low Density Lipoprotein Oxidation Relates to Coronary Reactivity in Young Men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Levels of soluble cell adhesion molecules in patients with dyslipidemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Plasma cholesterol regulates soluble cell adhesion molecule expression in familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Low-density lipoproteins inhibit the Na+/H+ antiport in human platelets. A novel mechanism enhancing platelet activity in hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Aging-associated endothelial dysfunction in humans is reversed by L-arginine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Hypercholesterolemia increases endothelial superoxide anion production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Effect of antioxidant vitamins on low density lipoprotein oxidation and impaired endothelium-dependent vasodilation in patients with hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Vitamin C improves endothelial dysfunction of epicardial coronary arteries in hypertensive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Evidence that endothelial dysfunction in patients with hypercholesterolemia is not due to increased extracellular nitric oxide breakdown by superoxide anions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

The effect of probucol on femoral atherosclerosis: The Probucol Quantitative Regression Swedish Trial (PQRST)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

The endothelin system. A new target for therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Enhanced endothelin-mediated coronary vasoconstriction and attenuated basal nitric oxide activity in experimental hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Exercise-induced vasomotion of angiographically normal and stenotic coronary arteries improves after cholesterol-lowering drug therapy with bezafibrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Effect of gemfibrozil +/- niacin +/- cholestyramine on endothelial function in patients with serum low-density lipoprotein cholesterol levels <160 mg/dl and high-density lipoprotein cholesterol levels <40 mg/dl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Endothelial dysfunction is associated with cholesterol levels in the high normal range in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

HMG-CoA Reductase Inhibitors Decrease CD11b Expression and CD11b-Dependent Adhesion of Monocytes to Endothelium and Reduce Increased Adhesiveness of Monocytes Isolated From Patients With Hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Functional evaluation of lipid-lowering therapy by pravastatin in the Regression Growth Evaluation Statin Study (REGRESS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Effect of cholesterol reduction on myocardial ischemia in patients with coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Reversal of coronary heart disease by lipid-lowering therapy. Observations and pathological mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Antioxidants and atherosclerotic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Additional benefit of vitamin E supplementation to simvastatin therapy on vasoreactivity of the brachial artery of hypercholesterolemic men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Effects of vitamin E on endothelial function in men after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: reversibility with oral L-arginine but not vitamin C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900261-2

10.1016/S0002-9343(99)00261-2

7 January 2021

Identifiers

DOI

1 reference

release_vxbn7qexajhhjhhbhih2gszyty

29 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vxbn7qexajhhjhhbhih2gszyty

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

10569303

1 reference

PubMed ID

10569303